1,569
Views
6
CrossRef citations to date
0
Altmetric
Research Article

Antifungal and antioxidant activities of Coleonema album and C. pulchellum against skin diseases

, , , , &
Pages 1249-1255 | Received 06 Jun 2016, Accepted 01 Jan 2017, Published online: 05 Mar 2017

References

  • Al Burtamani SK, Fatope MO, Marwah RG, Onifade AK, Alsaidi SH. 2005. Chemical composition, antibacterial and antifungal activities of the essential oil of Haplophyllum tuberculatum from Oman. J Ethnopharmacol. 96:107–112.
  • Alexander M. 2001. Aromatherapy & immunity: how the use of essential oil aids immune potentiality: part 3 immune responses to inflammation and essential oils useful in inhibiting them. Int J Aromather. 11:220–224.
  • Başer KHC, Demirci B, Özek T, Viljoen AM, Victor JE. 2006. Composition of the essential oils of five Coleonema species from South Africa. J Essent Oil Res. 18:26–29.
  • Baskaran P, Moyo M, Van Staden J. 2014. In vitro plant regeneration, phenolic compound production and pharmacological activities of Coleonema pulchellum. S Afr J Bot. 90:74–79.
  • Baylac S, Racine P. 2003. Inhibition of 5-lipoxygenase by essential oils and other natural fragrant extracts. Int J Aromather. 13:138–142.
  • Bhagra S, Ganju SA, Sood A, Guleria RC, Kanga AK. 2013. Microsporum gypseum dermatophytosis in a patient of acquired immunodeficiency syndrome: a rare case report. Indian J Med Microbiol. 31:295–298.
  • Braconi D, Bernardini G, Santucci A. 2010. Post-genomics and skin inflammation (review article). Mediat Inflamm. 2010:1–12.
  • Brader G, Bacher M, Hofer O, Greger H. 1997. Prenylated phenylpropenes from Coleonema pulchellum with antimicrobial activity. Phytochemistry. 45:1207–1212.
  • Briganti S, Picardo M. 2003. Antioxidant activity, lipid peroxidation and skin diseases. What's new. J Eur Acad Dermatol Venereol. 17:663–669.
  • Brophy JJ, Lassak EV. 1986. Volatile leaf oil of Coleonema pulchellum I. Williams (Rutaceae). Flavour Frag J. 1:155–157.
  • Candi E, Schmidt R, Melino G. 2005. The cornified envelope: a model of cell death in the skin. Nat Rev Mol Cell Biol. 6:328–340.
  • Catalá A. 2009. Lipid peroxidation of membrane phospholipids generates hydroxy-alkenals and oxidized phospholipids active in physiological and/or pathological conditions. Chem Phys Lipids. 157:1–11.
  • Chisolm GM, Steinberg D. 2000. The oxidative modification hypothesis of atherogenesis: an overview. Free Radic Biol Med. 8:1815–1826.
  • Clinical Laboratory Standards. 2002. Reference method for broth dilution antifungal susceptibility testing of filamentous fungi. Approved standard M38-A. National Committee for Clinical Laboratory Standards, Wayne, Pennysylvia.
  • Deigner HP, Hermetter A. 2008. Oxidized phospholipids: emerging lipid mediators in pathophysiology. Curr Opin Lipidol. 19:289–294.
  • Demmig-Adams B, Adams WW. 2002. Antioxidants in photosynthesis and human nutrition. Science. 298:2149–2153.
  • Dreyer DL, Pickering MV, Cohan P. 1972. Distribution of limnoids in the Rutaceae. Phytochemistry. 11:705–713.
  • Eldeen IMS, Van Staden J. 2008. Anti-inflammatory and mycobacterial activity of leaf extracts of Coleonema album. S Afr J Bot. 74:345–347.
  • Esterhuizen LL, Meyer R, Dubery I. 2006b. Antioxidant activity of metabolites from Coleonema album (Rutaceae). Nat Prod Commun. 1:367–375.
  • Esterhuizen LL, Meyer R, Dubery IA. 2006a. Antimicrobial compounds from Coleonema album (Rutaceae). Z Naturforsch C. 61:489–498.
  • Fajinmi OO, Amoo SO, Finnie JF, Van Staden J. 2014. Optimization of in vitro propagation of Coleonema album, a highly utilized medicinal and ornamental plant. S Afr J Bot. 94:9–13.
  • Fajinmi OO, Kulkarni MG, Finnie JF, Van Staden J. 2013. Factors influencing seed germination of Coleonema album – an aromatic and medicinal plant. Seed Sci Technol. 41:303–309.
  • Fernandes CN, Lamy F, Akiti T, Barreiros MG. 1998. Microsporum gypseum infection in AIDS patient: a case report. J An Bras Dermatol. 73:39–41.
  • Goodman DS, Telplitz ED, Wilshner A, Klein RS, Burk PG, Hershenbaum E. 1987. Prevalence of cutaneous disease in patients with acquired immunodeficiency syndrome (AIDS) or AIDS related complex. J Amer Acad Dermatol. 17:210–220.
  • Gray AI, Waterman PG. 1978. Coumarins in the Rutaceae. Phytochemistry. 17:845–864.
  • Gray AI. 1981. New coumarins from Coleonema album. Phytochemistry. 20:1711–1713.
  • Gutteridge JMC. 1988. Lipid peroxidation: some problems and concepts, In: Halliwell B, editor. Oxygen radicals and tissue injury. USA: FASEB; p. 9–19.
  • Halliwell B, Aruoma OI. 1991. DNA damage by oxygen-derived species. Its mechanism and measurement in mammalian systems. FEBS Lett. 281:9–19.
  • Havlickova B, Czaika VA, Friedrich M. 2008. Epidemiological trends in skin mycoses worldwide. Mycoses. 51:2–15.
  • Heim KE, Tagliaferro AR, Bobilya DJ. 2002. Flavonoid antioxidants: chemistry, metabolism and structure-activity relationships. J Nutr Biochem. 13:572–584.
  • Heinecke JW. 1998. Oxidants and antioxidants in the pathogenesis of atherosclerosis: implications for the oxidized low density lipoprotein hypothesis. Atherosclerosis. 141:1–15.
  • Ho KM, Wong KH. 2001. Dermatologic manifestations in HIV disease. In: Chan KCW, Wong KH, Lee SS, editors. HIV Manual. Hong Kong: Integrated Treatment Centre, Special Preventive Programmes, Department of Health. p. 231–245.
  • Hoult JRS, Paya M. 1996. Pharmacological and biochemical actions of simple coumarins: natural products with therapeutic potential. Gen Pharmacol. 27:713–722.
  • Howell MD, Kim BE, Gao P, Grant AV, Boguniewicz M, Debenedetto A, Schneider L, Beck LA, Barnes KC, Leung DY. 2009. Cytokine modulation of atopic dermatitis filaggrin skin expression. J Allergy Clin Immunol. 124:7–12.
  • Karamanos AJ, Sotiropoulou DEK. 2013. Field studies of nitrogen application on Greek oregano (Origanum vulgare) essential oil during two cultivation seasons. Ind Crop Prod. 46:246–252.
  • Kayser O, Kolodziej H. 1999. Antibacterial activity of simple coumarins: structural requirements for biological activity. Z Naturforsch C. 54:169–174.
  • Kostova I. 2006. Synthetic and natural coumarins as antioxidants. Mini Rev Med Chem. 6:365–374.
  • Kruk J, Duchnik E. 2014. Oxidative stress and skin diseases: possible role of physical activity. Asian Pac J Cancer Prev. 15:561–568.
  • Laurin P, Ferroud D, Klich M, Dupuis-Hamelin C, Mauvais P, Lassaigne P, Bonnefoy A, Musicki B. 1999. Synthesis and in vitro evaluation of novel highly potent coumarin inhibitors of gyrase B. Bioorg Med Chem Lett. 19:2079–2084.
  • Liebenberg L. 2008. Evaluation of biologically active compounds in Coleonema album. [Masters Degree Dissertation]. South Africa: University of Johanessburg.
  • Lis-Balchin M, Hart S. 2002. Coleonema album: studies of the pharmacological action on smooth muscle in vitro and antimicrobial action of its essential oil. Phytother Res. 16:292–294.
  • Lü ZR, Kim WS, Cho IH, Park D, Bhak J, Shi L, Zhou HW, Lee DY, Park YD, Yang JM, et al. 2009. DNA microarray analyses and interactomic predictions for atopic dermatitis. J Dermatol Sci. 55:123–125.
  • Marenholz I, Nickel R, Rüschendorf F, Schulz F, Esparza-Gordillo J, Kerscher T, Grüber C, Lau S, Worm M, Keil T, et al. 2006. Filaggrin loss-of-function mutations predispose to phenotypes involved in the atopic march. J Allergy Clin Immunol. 118:866–871.
  • Martinez-Cayuela M. 1995. Oxygen free radicals and human disease. Biochimica. 77:147–161.
  • Moure A, Cruz JM, Franco D, Dominquez JM, Sineiro J, Dominquez H, Nunez MJ, Parajo JC. 2001. Natural antioxidants from residual sources. Food Chem. 72:145–171.
  • National Aids and STI Control Program. 2008. Dermatological manifestations of the HIV disease. In: National manual for the management of HIV-related opportunistic infections and conditions. Baltech Equipments Limited., Kenya, pp. 67–72.
  • Nguyen T, Brunson D, Crespi CL, Penman BW, Wishnok JS, Tannenbaum SR. 1992. DNA damage and mutation in human cells exposed to nitric oxide in vitro. Proc Natl Acad Sci USA. 89:3030–3034.
  • Niki E. 2009. Lipid peroxidation: physiological levels and dual biological effects. Free Radic Biol Med. 47:469–484.
  • Okunade AL, Elvin-Lewis MPF, Lewis WH. 2004. Natural antimycobacterial metabolites: current status. Phytochemistry. 65:1017–1032.
  • Ou B, Hampsch-Woodill M, Prior RL. 2001. Development and validation of an improved oxygen radical absorbance capacity assay using fluorescein as the fluorescent probe. J Agric Food Chem. 49:4619–4626.
  • Palmer CNA, Irvine AD, Terron-Kwiatkowski A, Zhao Y, Liao H, Lee SP, Goudie DR, Sandilands A, Campbell LE, Smith FJ, et al. 2006. Common loss-of-function variants of the epidermal barrier protein filaggrin are a major predisposing factor for atopic dermatitis. Nat Genet. 38:441–446.
  • Pandey A, Pandey M. 2013. Isolation and characterization of dermatophytes with Tinea infections at Gwalior (MP), India. Int J Pharm Sci Invent. 2:5–8.
  • Preedy VR. 2015. Essential oil in food preservation, flavour and safety. 1st ed. London: Academic Press.
  • Rhind JP. 2012. Aromatherapeutic blending: Essential oils in synergy. 1st ed. London: Singing Dragon.
  • Rice-Evans CA, Burdon RH. 1994. Free radical damage and its control. 1st ed. Amsterdam, Netherlands: Elsevier.
  • Rudikoff D. 2002. The relationship between HIV infection and atopic dermatitis. Curr Allergy Asthma Rep. 2:275–281.
  • Schafer M, Farwanah H, Willrodt A, Huebner AJ, Sandhoff K, Roop D, Hohl D, Bloch W, Werner S. 2012. Nrf2 links epidermal barrier function with antioxidant defense. EMBO Mol Med. 4:364–379.
  • Sharma N, Tripathi A. 2006. Fungitoxicity of the essential oil of Citrus sinensis on post-harvest pathogens. World J Microbiol Biotechnol. 22:587–593.
  • Sivaranjani N, Rao VS, Rajeev G. 2013. Role of reactive oxygen species and antioxidants in atopic dermatitis. J Clin Diagn Res. 7:2683–2685.
  • Soares LA, De Cássia J, Sardi O, Gullo FP, De Souza NP, Scorzoni L, Leite FS, Soares MJ, Giannini M, Almeida AMF. 2013. Anti dermatophytic therapy-prospects for the discovery of new drugs from natural products. Braz J Microbiol. 44:1035–1041.
  • Stadtman ER. 1994. Protein modification in oxidative stress. In: Paoletti R, Samuelsson B, Catapano AL, Poli A, Rinetti M, editors. Oxidative processes and antioxidants. New York: Raven Press; p. 117–134.
  • Thestrup PK. 2000. Clinical aspects of atopic dermatitis. Clin Exp Dermatol. 25:535–543.
  • Thiele JJ. 2001. Oxidative targets in the stratum corneum. A new basis for antioxidative strategies. Skin Pharmacol Appl Skin Physiol. 14:87–91.
  • Trouba KJ, Hamadeh HK, Amin RP, Germolec DR. 2002. Oxidative stress and its role in skin disease. Antioxid Redox Signal. 4:665–673.
  • Tse ICT. 2007. Dermatologic manifestations in HIV disease. In: Lee SS, Wu JCY, Wong K, editors, HIV Manual 2007. Hong Kong: Hong Kong Special Administrative Region Government; p. 231–245.
  • Van Wyk B-E, Gericke N. 2000. People's plants. A guide to useful plants of Southern Africa. 1st ed. Briza, Pretoria, South Africa: Briza Publications.
  • Wagener FADTG, Carels CE, Lundvig DMS. 2013. Targeting the redox balance in inflammatory skin conditions: review. Int J Mol Sci. 14:9126–9167.
  • Weidinger S, Illig T, Baurecht H, Irvine AD, Rodriguez E, Diaz-Lacava A, Klopp N, Wagenpfeil S, Zhao Y, Liao H, et al. 2006. Loss-of-function variations within the filaggrin gene predispose for atopic dermatitis with allergic sensitizations. J Allergy Clin Immunol. 118:214–219.
  • Wink DA, Kasprzak KS, Maragos CM, Elespuru RK, Misra M, Dunams TM, Cebula TA, Koch WH, Andrew AW, et al. 1991. DNA deaminating ability and genotoxicity of nitric oxide and its progenitors. Science. 254:1001–1003.
  • Wood WF, Weldon PJ. 2002. The scent of the reticulate giraffe (Giraffa camelopardalis reticulata). Biochem Syst Ecol. 30:913–917.
  • Yasser AS, Nabil HO. 2012. Anti-inflammatory new coumarin from the Ammi majus L. Org Med Chem Lett. 2:1–4.